Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C14H19NO4 |
Molecular Weight | 265.305 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCOC1=C(OC)C=CC(=C1)[C@]2(C)CNC(=O)O2
InChI
InChIKey=PCCPERGCFKIYIS-AWEZNQCLSA-N
InChI=1S/C14H19NO4/c1-4-7-18-12-8-10(5-6-11(12)17-3)14(2)9-15-13(16)19-14/h5-6,8H,4,7,9H2,1-3H3,(H,15,16)/t14-/m0/s1
Molecular Formula | C14H19NO4 |
Molecular Weight | 265.305 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/15576036
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15576036
Daxalipram is a selective inhibitor of phosphodiesterase (PDE) 4B.This compound is an R-isomer of mesopram and is known as (R)-mesopram. Mesopram is known to trigger ovulation and exhibits efficacy against experimental autoimmune encephalomyelitis and murine colitis in vivo. Moreover, is used in compositions for the treatment or prevention of respiratory inflammation.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q07343 Gene ID: 5142.0 Gene Symbol: PDE4B Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/15576036 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:16:22 GMT 2023
by
admin
on
Fri Dec 15 16:16:22 GMT 2023
|
Record UNII |
0RB5T277IY
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C744
Created by
admin on Fri Dec 15 16:16:22 GMT 2023 , Edited by admin on Fri Dec 15 16:16:22 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2107739
Created by
admin on Fri Dec 15 16:16:22 GMT 2023 , Edited by admin on Fri Dec 15 16:16:22 GMT 2023
|
PRIMARY | |||
|
100000174984
Created by
admin on Fri Dec 15 16:16:22 GMT 2023 , Edited by admin on Fri Dec 15 16:16:22 GMT 2023
|
PRIMARY | |||
|
DB01647
Created by
admin on Fri Dec 15 16:16:22 GMT 2023 , Edited by admin on Fri Dec 15 16:16:22 GMT 2023
|
PRIMARY | |||
|
C83653
Created by
admin on Fri Dec 15 16:16:22 GMT 2023 , Edited by admin on Fri Dec 15 16:16:22 GMT 2023
|
PRIMARY | |||
|
189940-24-7
Created by
admin on Fri Dec 15 16:16:22 GMT 2023 , Edited by admin on Fri Dec 15 16:16:22 GMT 2023
|
PRIMARY | |||
|
8410
Created by
admin on Fri Dec 15 16:16:22 GMT 2023 , Edited by admin on Fri Dec 15 16:16:22 GMT 2023
|
PRIMARY | |||
|
449190
Created by
admin on Fri Dec 15 16:16:22 GMT 2023 , Edited by admin on Fri Dec 15 16:16:22 GMT 2023
|
PRIMARY | |||
|
DTXSID001319171
Created by
admin on Fri Dec 15 16:16:22 GMT 2023 , Edited by admin on Fri Dec 15 16:16:22 GMT 2023
|
PRIMARY | |||
|
0RB5T277IY
Created by
admin on Fri Dec 15 16:16:22 GMT 2023 , Edited by admin on Fri Dec 15 16:16:22 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|